Constraint Induced Movement Therapy on Infantile Hemiplegia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-01-31

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the functionality of the affected upper limb in infantile hemiplegia by applying a protocol of modified constraint-induced movement therapy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Upper Limb Intensive Therapies in Babies With Unilateral Cerebral Palsy.

NCT04642872

Infantile Hemiplegia Upper Extremity Paresis Family +2 more

UNKNOWN NA

Intensive Therapies in Children With Hemiplegia

NCT03465046

Infantile Hemiplegia

COMPLETED NA

Movement in the Non-use of the Affected Upper Extremity in Children Hemiparesis: Mirror Therapy and Action-observation

NCT04284176

Hemiplegia, Infantile

UNKNOWN NA

A Trial Comparing Two Methods of CIMT in the Hemiplegic Child

NCT01770678

Cerebral Palsy

COMPLETED PHASE2

Intensive Therapies to Improve Manipulation in Young Children With Hemiparesis

NCT06191588

Infantile Hemiplegia Constraint Induced Movement Therapy Family +1 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemiplegia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

UTWC (control group)

the control group performs the same tasks than the experimental group, but without healthy hand constraint/containment.

Group Type EXPERIMENTAL

Unimanual therapy without constraint UTWC

Intervention Type PROCEDURE

affected upper limb use without constraint of healthy hand

mCIMT

The study is conducted over a period of 5 weeks of treatment, using a movement restriction time healthy upper extremity of 2 hours daily.

The restriction applied in the study is performed with the closed hand position and thumb inside the fist through a transparent film that reaches the wrist joint.

In periods mCIMT, monitored the activities designed to enhance their functionality, based on motivation, avoiding frustrations are made.

Group Type EXPERIMENTAL

mCIMT

Intervention Type PROCEDURE

affected upper limb use with constraint of the healthy hand

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

mCIMT

affected upper limb use with constraint of the healthy hand

Intervention Type PROCEDURE

Unimanual therapy without constraint UTWC

affected upper limb use without constraint of healthy hand

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Modified constraint-induced movement therapy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children's Hemiplegia Medical diagnosis.
* Aged between 4 and 8 years.
* Lack of activity of the affected upper extremity.
* Overcoming 10th extension at the metacarpophalangeal and interphalangeal joint.
* Complete the 20 º of wrist extension of the affected upper extremity.
* Adequate cognitive development to understand verbal commands given for the execution of tasks.
* Cooperation in the execution of tasks.

Exclusion Criteria

* To Have vision problems that prevent them from carrying out the intervention.
* Having significant balance changes that endanger the child fall to bring a restriction in the affected upper limb.
* Submit uncontrolled seizures.
* To Have received botulinum toxin prior to 6 months prior to the intervention.

Minimum Eligible Age

4 Years

Maximum Eligible Age

8 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No